Key result
Diabetes warnings linked to increased healthcare utilization but better health outcomes only in high-risk individuals.
Why the study?
The marginal value of health information from checkup signals and its impact on healthcare utilization and outcomes across different risk groups was unclear.
Does receiving health warnings about diabetes improve health outcomes in individuals undergoing checkups?
Observational
Does receiving health warnings about diabetes improve health outcomes in individuals undergoing checkups?
Answers are grounded in this paper and cite their sources.
The marginal value of health information depends on setting appropriate thresholds for health warnings and targeting high-risk individuals most likely to benefit from follow-up medical care.
We investigate the marginal value of information in the context of health signals that people receive after checkups. Although underlying health status is similar for individuals just below and above a clinical threshold, treatments differ according to the checkup signals they receive. For the general population, whereas health warnings about diabetes increase healthcare utilization, health outcomes do not improve. However, among high-risk individuals, outcomes do improve, and improved health is worth its cost. These results indicate that the marginal value of health information depends on setting appropriate thresholds for health warnings and targeting individuals most likely to benefit from follow-up medical care.
No takes yet. Share an insight, caveat, or question.
Iizuka et al. (2021) conducted an observational in Diabetes. Health warnings about diabetes vs. No health warnings (just below clinical threshold) was evaluated on Health outcomes and healthcare utilization. Health warnings about diabetes increased healthcare utilization without improving health outcomes in the general population, but improved outcomes among high-risk individuals.
Synapse has enriched 10 related papers. Consider them for comparative context: